Page 20 | Certara

Poster

Mechanistic Modeling Guides Bispecific Antibody Design and Target Selection for Maximizing Therapeutic Window

Therapeutic antibodies have shown promise in treating diseases such as cancer, but selectivity remains a…

CertaraMarch 28, 2025

Press Coverage

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma's Almanac article about…

CertaraMarch 28, 2025

On-Demand Webinar

BaseCase Community Meetup 2025 – Session Recordings

Certara: Transforming Drug Development for Good Martin Snyder Basecase 2025 and Beyond: Preparing for Tomorrow’s…

CertaraMarch 28, 2025

On-Demand Webinar

The Revolution of Metadata Standardization with Clinical Metadata Repository (CMDR)

Solution Consultant, Software, APAC (Japan) Rico Fujita is a Software Solution Consultant in Japan, APAC.…

CertaraMarch 27, 2025

Video

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

CertaraMarch 27, 2025

Video

Behind the Science: Meet Project Manager Chantal Morin

CertaraMarch 27, 2025

Blog

Exploring Common CDISC ADaM Conformance Findings

March 27, 2025 ADaM data are required by the FDA and PMDA and accepted by…

CertaraMarch 27, 2025

Video

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

CertaraMarch 26, 2025

Video

Behind the Science: Meet Sr. Director Craig Comisar

CertaraMarch 26, 2025

Video

Behind the Science: Meet Project Manager Holly Dierkers

CertaraMarch 26, 2025

Mechanistic Modeling Guides Bispecific Antibody Design and Target Selection for Maximizing Therapeutic Window

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

BaseCase Community Meetup 2025 – Session Recordings

The Revolution of Metadata Standardization with Clinical Metadata Repository (CMDR)

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Behind the Science: Meet Project Manager Chantal Morin

Exploring Common CDISC ADaM Conformance Findings

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

Behind the Science: Meet Sr. Director Craig Comisar

Behind the Science: Meet Project Manager Holly Dierkers

Newsletter sign up

Quick links

Solutions

Contact